Overview

RCT of CBT Combined With D-Cycloserine for Treating PTSD

Status:
Unknown status
Trial end date:
2008-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate if the effectiveness of cognitive-behavioral therapy for post-traumatic stress disorder can be increased by combining it with D-cycloserine (TCC/D-cycloserine) by comparing with a placebo (TCC/placebo).
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Université de Montréal
Collaborators:
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine
Treatments:
Cycloserine
Criteria
Inclusion Criteria:

- Clinical diagnosis of PTSD

- No other Axix I disorder of higher intensity than PTSD

- Accept not to start a psychopharmacological treatment before and during the
participation to the project

Exclusion Criteria:

- Substance abuse

- Psychotic episodes (past or current)

- Bipolar disorder

- Organic caused mental disorder

- Intellectual deficiency

- Pregnant or breast-feeding woman

- Épilepsy